News: research
Trailblazer defence program formalised

The Defence Trailblazer for Concept to Sovereign CapabilityÌýprogram has taken another step in being formalised with the conditions of grant being finalised and the announcement of the board members.Ìý
Trailblazing new opportunities to commercialise defence research

A major defence research commercialisation project between the ÐÓ°ÉÖ±²¥ of Adelaide and the ÐÓ°ÉÖ±²¥ of New South Wales is one of just eight proposals shortlisted forÌýthe Federal Government’s new $242.7 million Trailblazer Universities program.
[Read more about Trailblazing new opportunities to commercialise defence research]
Fortescue Future Industries, Sparc Technologies and the ÐÓ°ÉÖ±²¥ of Adelaide partner to tackle the future of clean energy

Sparc Technologies Ltd (ASX: SPN) has entered into binding agreements with global green energy company Fortescue Future Industries Pty Ltd (an entity of Fortescue Metals Group Ltd ASX: FMG) and the ÐÓ°ÉÖ±²¥ of Adelaide, forming the Sparc Hydrogen Pty Ltd Joint Venture (Sparc Hydrogen).
ONLINE WORKSHOP: Tips to translate your research

One hour online workshops for ÐÓ°ÉÖ±²¥ of Adelaide's Life Sciences and Physical Sciences research staff led by ÐÓ°ÉÖ±²¥ of Adelaide investment partner, IP Group.
[Read more about ONLINE WORKSHOP: Tips to translate your research]
VivaZome licenses ÐÓ°ÉÖ±²¥ of Adelaide stem cell technology

VivaZome TherapeuticsÌýand the ÐÓ°ÉÖ±²¥ of Adelaide haveÌýentered into a series of agreements encompassing licensing of technology, access to stem cells and conduct of research, all in support of VivaZome’s mission to develop and commercialise exosome-based therapeutics.
[Read more about VivaZome licenses ÐÓ°ÉÖ±²¥ of Adelaide stem cell technology ]
Partnership to revolutionise cancer diagnostic

The ÐÓ°ÉÖ±²¥ of Adelaide has partnered with medical technology company Sienna Cancer Diagnostics in an exclusive worldwide licenceÌýagreement to develop a unique cancer probe with the potential to detect a sugar molecule only present in cancer cells.
[Read more about Partnership to revolutionise cancer diagnostic]